Nothing Special   »   [go: up one dir, main page]

IL131617A0 - 5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds - Google Patents

5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds

Info

Publication number
IL131617A0
IL131617A0 IL13161798A IL13161798A IL131617A0 IL 131617 A0 IL131617 A0 IL 131617A0 IL 13161798 A IL13161798 A IL 13161798A IL 13161798 A IL13161798 A IL 13161798A IL 131617 A0 IL131617 A0 IL 131617A0
Authority
IL
Israel
Prior art keywords
aminopyridol
trisubstituted
pyrimidine compounds
pyrimidine
compounds
Prior art date
Application number
IL13161798A
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL131617A0 publication Critical patent/IL131617A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13161798A 1997-04-16 1998-04-13 5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds IL131617A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84348497A 1997-04-16 1997-04-16
PCT/US1998/007201 WO1998046604A1 (en) 1997-04-16 1998-04-13 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
IL131617A0 true IL131617A0 (en) 2001-01-28

Family

ID=25290123

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13161798A IL131617A0 (en) 1997-04-16 1998-04-13 5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds

Country Status (19)

Country Link
EP (1) EP0975633A1 (en)
JP (1) JP2001520654A (en)
KR (1) KR20010006462A (en)
CN (1) CN1252069A (en)
AR (1) AR012437A1 (en)
AU (1) AU741033B2 (en)
BG (1) BG103853A (en)
BR (1) BR9809056A (en)
CA (1) CA2286592A1 (en)
CO (1) CO4940470A1 (en)
HU (1) HUP0001443A3 (en)
IL (1) IL131617A0 (en)
NO (1) NO995035L (en)
NZ (1) NZ337125A (en)
PL (1) PL336265A1 (en)
SK (1) SK140099A3 (en)
TR (1) TR199902550T2 (en)
WO (1) WO1998046604A1 (en)
ZA (1) ZA983175B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
RU2269527C2 (en) 2001-02-12 2006-02-10 Ф.Хоффманн-Ля Рош Аг Derivatives of pyridopyrimidines, methods for their preparing and pharmaceutical composition based on thereof
CN107744520A (en) * 2017-10-25 2018-03-02 南京多宝生物科技有限公司 Pyrimidines are preparing the application in promoting small bowel peristalsis medicine
CN112209924B (en) * 2019-07-09 2022-04-05 中国科学院天津工业生物技术研究所 selective adenosine A1 receptor antagonists
EP4343709B1 (en) * 2022-09-23 2024-10-30 Axis AB Method and image-processing device for determining a probability value indicating that an object captured in a stream of image frames belongs to an object type

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
TR199902550T2 (en) 2000-04-21
PL336265A1 (en) 2000-06-19
BR9809056A (en) 2000-08-01
WO1998046604A1 (en) 1998-10-22
HUP0001443A2 (en) 2000-10-28
CA2286592A1 (en) 1998-10-22
AU7108098A (en) 1998-11-11
BG103853A (en) 2000-06-30
HUP0001443A3 (en) 2001-01-29
EP0975633A1 (en) 2000-02-02
KR20010006462A (en) 2001-01-26
CO4940470A1 (en) 2000-07-24
AR012437A1 (en) 2000-10-18
JP2001520654A (en) 2001-10-30
SK140099A3 (en) 2000-05-16
NO995035L (en) 1999-12-15
NZ337125A (en) 2001-06-29
AU741033B2 (en) 2001-11-22
CN1252069A (en) 2000-05-03
ZA983175B (en) 1998-10-21
NO995035D0 (en) 1999-10-15

Similar Documents

Publication Publication Date Title
ZA989767B (en) Novel compounds.
HRP980398B1 (en) 5H-THIAZOLO /3,2-a/ PYRIMIDINE DERIVATIVES
ZA985323B (en) New compounds
ZA983177B (en) 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
HK1025955A1 (en) Novel pyrimidine derivative
ZA9811758B (en) Novel compounds.
ZA9811503B (en) Novel compounds.
ZA989839B (en) New spirocyciic compounds
IL136500A0 (en) 1,4-diazacycloheptane derivatives
ZA983736B (en) New compounds
EP0999205A4 (en) Aminocycloalkane compounds
IL131617A0 (en) 5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds
ZA982912B (en) 6,7-disubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
ZA98868B (en) Novel compounds.
AUPP003297A0 (en) 4,5-diaryloxazole compounds
GB9704522D0 (en) Compounds
ZA981529B (en) Substituted 2,4-diaminopyrimidine
GB9702978D0 (en) Compounds
IL150715A0 (en) Substituted pyrimidines
EP0954316A4 (en) Pyrimidine derivatives
IL166937A (en) Uracil compounds
ZA984303B (en) Novel compounds.
ZA982184B (en) Novel compounds.
ZA982185B (en) Novel compounds.